E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers P > Headlines for PDL BioPharma, Inc. > News item
Published on 7/29/2008 in the Prospect News Special Situations Daily.

Highland Capital sells 1.51 million shares of PDL BioPharma

By Lisa Kerner

Charlotte, N.C., July 29 - Investors led by Highland Capital Management, LP cut their stake in PDL BioPharma, Inc. to 6.9% from 8.1% with the sale of approximately 1.51 million shares of the company's stock.

The shares were sold on July 23 and July 24 priced at $11.07 and $10.73 per share, respectively, according to a schedule 13D filing with the Securities and Exchange Commission.

Highland owns 8.2 million shares of the Wilmington, N.C., pharmaceutical company's stock.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.